MRVL Pet Pharmaceuticals Corp. Announces Changes to Management and Board of Directors
Company or
MRVL ), a life sciences and technology company focused on the animal health sector, is pleased to announce the appointments of Dr. Joel Beth Navratik, current Chief Executive Officer (
CEO ) of the Company, as President and a Director of the Company, and Ivan Hsu as Chief Operating Officer (
COO ) and Chief Financial Officer (
CFO ) of the Company, effective May 31, 2021, following the resignations of Derrick Gaon as Director and President and Ronald Ozols as CFO, Vice President, and Corporate Secretary.
The Company is also pleased to announce the appointments of Vyvyan Campbell and Patricia Trompeter to the Company s Board of Directors (the
MRVL Pet Pharmaceuticals(TM) Corp. Announces Changes to Management and Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
(2)
Vancouver, British Columbia (Newsfile Corp. - January 29, 2021) - EGF Health Holdings Corp. (the Company ) announced today that it has increased its private placement to up to 12,307,692 units at a price of $0.325 per unit for gross proceeds of up to $4,000,000. Each unit consists of one common share and a half warrant. Each whole warrant will entitle the subscriber to purchase an additional common share at an exercise price of $0.50 per share for a period of one year from the closing of the private placement.
The first tranche of the private placement consisting of 6,515,277 units and proceeds of $2,117,465 closed on January 8, 2021.
The proceeds from the private placement will be used for general working capital and for the closing of the MRVL Island Ventures Ltd. transaction. Finder s fees will be paid on the private placement.
EGF Health Holdings Corp.: EGF Health Closes Private Placement
Vancouver, British Columbia (Newsfile Corp. - January 13, 2021) - EGF Health Holdings Corp. announced today that it has closed a private placement of 6,515,277 units at a price of $0.325 per unit for gross proceeds of $2,117,465. Each unit consisted of one common share and a half warrant. Each whole warrant will entitle the subscriber to purchase an additional common share at an exercise price of $0.50 per share on or before January 8, 2022.
Finder s fees of $43,973 were paid on the private placement. In addition, 135,300 Finders Warrants were issued with an exercise price of $0.50 per share and an expiry date January 8, 2022.
Vancouver, British Columbia (Newsfile Corp. - January 8, 2021) - EGF Health Holdings Corp. announced today a private placement of up to 7,692,307 units at a price of $0.325 per unit for gross proceeds